One in five people in the world suffers from fungal diseases, according to the World Health Organization (WHO).
Among the causative agents of nosocomial infections in patients in emergency and intensive care departments, Candіda fungi rank No. 4. Fluconazole is the drug of choice for treatment of infections caused by Candіda fungi, regardless of localization, including candidemia.
The product’s half-life is 30 hours, which makes it possible to administer the solution once daily.
Intravenous administration of Fluconazole is highly effective for treatment of fungal infections of any location that guarantees minimum duration of treatment in acute uncomplicated forms of diseases and high anti-relapsing effect.